IR@PKUHSC  > 北京大学第二临床医学院
学科主题临床医学
Effect of CD3+ cell dose on outcome in patients after conditioning including antithymocyte globulin followed by un-manipulated HLA-mismatched/haploidentical blood and marrow transplantation
Dong, L.; Wu, T.; Lu, D. -P.; Zhang, M. . -J.; Chen, H.; Gao, Z. Y.; Han, W.; Zhang, Y. -C.; Wang, J. -B.; Liu, Y. R.
刊名BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
2007-02-01
suppl.2期:2页:122-123
收录类别ISTP ; SCI
文章类型Meeting Abstract
WOS标题词Science & Technology
类目[WOS]Hematology ; Immunology ; Transplantation
研究领域[WOS]Hematology ; Immunology ; Transplantation
语种英语
WOS记录号WOS:000244028300339
引用统计
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/65250
专题北京大学第二临床医学院
作者单位1.Peking Univ, People Hosp, Beijing 100871, Peoples R China
2.Dao Pei Hosp, Beijing, Peoples R China
3.Med Coll Wisconsin, Div Biostat, Milwaukee, WI 53226 USA
推荐引用方式
GB/T 7714
Dong, L.,Wu, T.,Lu, D. -P.,et al. Effect of CD3+ cell dose on outcome in patients after conditioning including antithymocyte globulin followed by un-manipulated HLA-mismatched/haploidentical blood and marrow transplantation[J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION,2007,suppl.2(2):122-123.
APA Dong, L..,Wu, T..,Lu, D. -P..,Zhang, M. . -J..,Chen, H..,...&Liu, Y. R..(2007).Effect of CD3+ cell dose on outcome in patients after conditioning including antithymocyte globulin followed by un-manipulated HLA-mismatched/haploidentical blood and marrow transplantation.BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION,suppl.2(2),122-123.
MLA Dong, L.,et al."Effect of CD3+ cell dose on outcome in patients after conditioning including antithymocyte globulin followed by un-manipulated HLA-mismatched/haploidentical blood and marrow transplantation".BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION suppl.2.2(2007):122-123.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Dong, L.]的文章
[Wu, T.]的文章
[Lu, D. -P.]的文章
百度学术
百度学术中相似的文章
[Dong, L.]的文章
[Wu, T.]的文章
[Lu, D. -P.]的文章
必应学术
必应学术中相似的文章
[Dong, L.]的文章
[Wu, T.]的文章
[Lu, D. -P.]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。